542 related articles for article (PubMed ID: 19204941)
1. Prognostic influence of sub-stages according to pTNM categories in patients with stage IV gastric cancer.
Li C; Yan M; Chen J; Xiang M; Zhu ZG; Lin YZ
J Surg Oncol; 2009 May; 99(6):324-8. PubMed ID: 19204941
[TBL] [Abstract][Full Text] [Related]
2. pN3M0 gastric cancer: the category that allows the sub-classification of stage-IV gastric cancer (IVa and IVb).
Park JM; Park SS; Mok YJ; Kim CS
Ann Surg Oncol; 2007 Sep; 14(9):2535-42. PubMed ID: 17549571
[TBL] [Abstract][Full Text] [Related]
3. Proposal to subclassify stage IV gastric cancer into IVA, IVB, and IVM.
An JY; Ha TK; Noh JH; Sohn TS; Kim S
Arch Surg; 2009 Jan; 144(1):38-45; discussion 45. PubMed ID: 19153323
[TBL] [Abstract][Full Text] [Related]
4. Subclassification of stage IV gastric cancer (IVa, IVb, and IVc) and prognostic significance of substages.
Ma Y; Xue Y; Li Y; Lan X; Zhang Y; Zhang M
J Gastrointest Surg; 2010 Mar; 14(3):484-92. PubMed ID: 19949998
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of long-term results of radical gastrectomy combining splenectomy for gastric cancer].
Han FH; Zhan WH; Li YM; He YL; Peng JS; Ma JP; Wang Z; Chen ZX; Zheng ZQ; Wang JP; Huang YH; Dong WG
Zhonghua Wai Ke Za Zhi; 2005 Sep; 43(17):1114-7. PubMed ID: 16194307
[TBL] [Abstract][Full Text] [Related]
6. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
Anticancer Res; 2000; 20(2B):1285-9. PubMed ID: 10810436
[TBL] [Abstract][Full Text] [Related]
7. Surgical resection of stage IV gastric cancer and prognosis.
Yamashita K; Sakuramoto S; Kikuchi S; Katada N; Kobayashi N; Watanabe M
Anticancer Res; 2007; 27(6C):4381-6. PubMed ID: 18214048
[TBL] [Abstract][Full Text] [Related]
8. Surgical outcome of 483 patients with early gastric cancer: prognosis, postoperative morbidity and mortality, and gastric remnant cancer.
Onodera H; Tokunaga A; Yoshiyuki T; Kiyama T; Kato S; Matsukura N; Masuda G; Tajiri T
Hepatogastroenterology; 2004; 51(55):82-5. PubMed ID: 15011835
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series.
Marchet A; Mocellin S; Ambrosi A; de Manzoni G; Di Leo A; Marrelli D; Roviello F; Morgagni P; Saragoni L; Natalini G; De Santis F; Baiocchi L; Coniglio A; Nitti D;
Eur J Surg Oncol; 2008 Feb; 34(2):159-65. PubMed ID: 17566691
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for patients with node-negative gastric cancer: Can extended lymph node dissection have a survival benefit?
Park SS; Park JM; Kim JH; Kim WB; Lee J; Kim SJ; Kim CS; Mok YJ
J Surg Oncol; 2006 Jul; 94(1):16-20. PubMed ID: 16788938
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological features, surgical management, and disease outcome of perforated gastric cancer.
Jwo SC; Chien RN; Chao TC; Chen HY; Lin CY
J Surg Oncol; 2005 Sep; 91(4):219-25. PubMed ID: 16121341
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological characteristics of stage 1 gastric cancer: comparison of macroscopic and microscopic findings.
Baba H; Ohshiro T; Yamamoto M; Endo K; Adachi E; Kakeji Y; Kohnoe S; Maehara Y; Sugimachi K
Hepatogastroenterology; 1997; 44(14):554-8. PubMed ID: 9164536
[TBL] [Abstract][Full Text] [Related]
13. Classification of lymph node metastases from gastric cancer: comparison between N-site and N-number systems. Our experience and review of the literature.
Aurello P; D'Angelo F; Rossi S; Bellagamba R; Cicchini C; Nigri G; Ercolani G; De Angelis R; Ramacciato G
Am Surg; 2007 Apr; 73(4):359-66. PubMed ID: 17439029
[TBL] [Abstract][Full Text] [Related]
14. Suitability of 7th UICC N stage for predicting the overall survival of gastric cancer patients after curative resection in China.
Deng J; Liang H; Sun D; Wang D; Pan Y
Ann Surg Oncol; 2010 May; 17(5):1259-66. PubMed ID: 20217252
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and clinical evaluation of patients with T2 gastric cancer.
Komatsu S; Ichikawa D; Kurioka H; Kan K; Shioaki Y; Ueshima Y; Hamashima T; Lee CJ; Ikeda E; Ueda Y; Otsuji E; Oka T; Yamagishi H
Hepatogastroenterology; 2005; 52(63):965-8. PubMed ID: 15966242
[TBL] [Abstract][Full Text] [Related]
16. Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups?
Lim S; Muhs BE; Marcus SG; Newman E; Berman RS; Hiotis SP
J Surg Oncol; 2007 Feb; 95(2):118-22. PubMed ID: 17262741
[TBL] [Abstract][Full Text] [Related]
17. Indications for paraaortic lymph node dissection in gastric cancer patients with paraaortic lymph node involvement.
Kunisaki C; Shimada H; Yamaoka H; Takahashi M; Ookubo K; Akiyama H; Nomura M; Moriwaki Y
Hepatogastroenterology; 2000; 47(32):586-9. PubMed ID: 10791244
[TBL] [Abstract][Full Text] [Related]
18. Predictors of long-term survival in pN3 gastric cancer patients.
Kim J; Cheong JH; Hyung WJ; Shen J; Choi SH; Noh SH
J Surg Oncol; 2004 Oct; 88(1):9-13. PubMed ID: 15384089
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological characteristics and outcome indicators of stage II gastric cancer according to the Japanese classification of gastric cancer.
Ojima H; Araki K; Kato T; Okamura K; Manda R; Hirayama I; Hosouchi Y; Nishida Y; Kuwano H
Anticancer Res; 2006; 26(2B):1385-90. PubMed ID: 16619548
[TBL] [Abstract][Full Text] [Related]
20. Modified radical lymphadenectomy without splenectomy in patients with proximal gastric cancer: comparison with standard D2 lymphadenectomy for distal gastric cancer.
Cheong O; Kim BS; Yook JH; Oh ST; Park YK; Ryu SY
J Surg Oncol; 2008 Dec; 98(7):500-4. PubMed ID: 18770520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
